January 29, 2015 12:00 PM ET


Company Overview of Okairos AG

Company Overview

Okairos AG operates as a clinical-stage biopharmaceutical company that engages in the discovery, development, and commercialization of T-cell based vaccines for infectious diseases and cancer. It focuses on developing vaccines for hepatitis C virus, malaria, HIV, respiratory syncytial virus, and influenza, as well as cancer. The company was founded in 2007 and is headquartered in Basel, Switzerland with laboratories in Rome and Naples, Italy. As of May 29, 2013, Okairos AG operates as a subsidiary of GlaxoSmithKline plc.

Aeschenvorstadt 71

Basel,  4051


Founded in 2007


41 61 270 35 35


41 61 270 35 00

Key Executives for Okairos AG

Co-Founder and Chief Scientific Officer
Co-Founder and Senior Director of Vector Development
Co-Founder and Director of Immunology
Chief Operating Officer
Compensation as of Fiscal Year 2014.

Okairos AG Key Developments

Okairos AG Initiates Phase I Clinical Trial Evaluating Vaccine against RSV Infections

Okairos AG announced the initiation of a Phase I clinical trial evaluating a vaccine against respiratory syncytial virus (RSV), a cause of hospital admissions in infants and children. This clinical trial will enroll 40 healthy adult volunteers in the UK, with endpoints measuring the vaccine's safety and immunogenicity. RSV is responsible for up to 126,000 infant hospitalizations for pneumonia or bronchiolitis every year in the US alone, according to the World Health Organization. There are currently no vaccines that protect children against RSV infections, and treatment options are limited.

Similar Private Companies By Industry

Company Name Region
JRS Rettenmaier AG Europe
ACIC Europe Limited Europe
Amal Therapeutics SA Europe
Biocon SA Europe
Cilag GmbH International Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Okairos AG, please visit www.okairos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.